PXN and type 2 diabetes mellitus: Our results agree with previous evidence indicating that diabetes and chronic hyperglycemia are linked to the upregulation of integrin and paxillin pathways and the downregulation of RhoGDP dissociation inhibitor responses [44,45,46] and the exacerbated T-cell activation and chronic low-grade inflammation present in T2D and its complications [47,48].